HVC
SUPN icon

Healthcare Value Capital’s Supernus Pharmaceuticals SUPN Stock Holding History

Healthcare Value Capital’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-106,735
Closed -$951K – 38
2014
Q1 		$954K Sell
106,735
-944,010
-90% -$8.69M 0.62% 31
2013
Q4 		$7.92M Buy
1,050,745
+185,000
+21% +$1.29M 5.81% 6
2013
Q3 		$6.35M Buy
865,745
+143,431
+20% +$963K 5.55% 3
2013
Q2 		$4.64M Buy
+722,314
New +$4.25M 3.37% 5

Other funds holding SUPN

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
MRM
Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Healthcare Value Capital's SUPN Position: Q2 2014 in Review

Healthcare Value Capital sold out of Supernus Pharmaceuticals (SUPN) in Q2 2014, closing a stake of 106,735 shares — an estimated $951K sold.

Healthcare Value Capital first reported a position in SUPN in Q2 2013 and held it in 4 quarters. The position peaked at $7.92M in Q4 2013. 88 funds tracked by Wall St. Rank hold SUPN as of Q2 2014.

  • Healthcare Value Capital reported no remaining Supernus Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Healthcare Value Capital sold 106,735 Supernus Pharmaceuticals shares in Q2 2014, an estimated $951K.
  • Healthcare Value Capital first reported a position in Supernus Pharmaceuticals in Q2 2013 and held it in 4 quarters.
  • Healthcare Value Capital's Supernus Pharmaceuticals position peaked at $7.92M in Q4 2013.
  • 88 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2014.

Based on Healthcare Value Capital's 13F filing for Q2 2014, filed 13 Aug 2014.